Poon, R. T., & Borys, N. (2011). Lyso-thermosensitive liposomal doxorubicin: An adjuvant to increase the cure rate of radiofrequency ablation in liver cancer. Future oncology (London, England), 7(8), 937-945. https://doi.org/10.2217/fon.11.73
Chicago Style (17th ed.) CitationPoon, Ronnie TP, and Nicholas Borys. "Lyso-thermosensitive Liposomal Doxorubicin: An Adjuvant to Increase the Cure Rate of Radiofrequency Ablation in Liver Cancer." Future Oncology (London, England) 7, no. 8 (2011): 937-945. https://doi.org/10.2217/fon.11.73.
MLA (9th ed.) CitationPoon, Ronnie TP, and Nicholas Borys. "Lyso-thermosensitive Liposomal Doxorubicin: An Adjuvant to Increase the Cure Rate of Radiofrequency Ablation in Liver Cancer." Future Oncology (London, England), vol. 7, no. 8, 2011, pp. 937-945, https://doi.org/10.2217/fon.11.73.